Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
The Most Famous Virtual Entertainment Powerhouses of the Year - 2One of the best meteor showers of the year peaks at the worst possible time this week
- 3Astonishing interstellar comet captured in new images by NASA Mars missions
- 4She was moments away from giving birth. The hospital discharged her
- 5Hamas demanded displaced Gazans pay rent on beach tents amid torrential downpour, IDF reveals
- Blue Origin launches New Glenn rocket on company's first NASA-scale science mission
- UK forecast to face weaker growth and higher inflation from Iran war
- Asia's Noteworthy Destinations: A Voyager's Aide
- Daily Briefing: A bad flu season gets worse
- Earth’s magnetic field protects life on Earth from radiation, but it can move, and the magnetic poles can even flip
- Ukraine: Russians abduct 50 Ukrainians from border village in Sumy
- Purchases of iPhone 17 Pro soar across Gaza amid 'limited' humanitarian aid
- Chinese mega embassy could bring security advantages, says No 10
- 6 Financial plan 3D Printers with the Best Worth
